Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Cytosolic PCNA interacts with p47phox and controls NADPH oxidase NOX2 activation in neutrophils.

Ohayon D, De Chiara A, Dang PM, Thieblemont N, Chatfield S, Marzaioli V, Burgener SS, Mocek J, Candalh C, Pintard C, Tacnet-Delorme P, Renault G, Lagoutte I, Favier M, Walker F, Hurtado-Nedelec M, Desplancq D, Weiss E, Benarafa C, Housset D, Marie JC, Frachet P, El-Benna J, Witko-Sarsat V.

J Exp Med. 2019 Sep 6. pii: jem.20180371. doi: 10.1084/jem.20180371. [Epub ahead of print]

PMID:
31492810
2.

Long-term cardiovascular disorders in the STOX1 mouse model of preeclampsia.

Miralles F, Collinot H, Boumerdassi Y, Ducat A, Duché A, Renault G, Marchiol C, Lagoutte I, Bertholle C, Andrieu M, Jacques S, Méhats C, Vaiman D.

Sci Rep. 2019 Aug 15;9(1):11918. doi: 10.1038/s41598-019-48427-3.

3.

β-catenin-activated hepatocellular carcinomas are addicted to fatty acids.

Senni N, Savall M, Cabrerizo Granados D, Alves-Guerra MC, Sartor C, Lagoutte I, Gougelet A, Terris B, Gilgenkrantz H, Perret C, Colnot S, Bossard P.

Gut. 2019 Feb;68(2):322-334. doi: 10.1136/gutjnl-2017-315448. Epub 2018 Apr 12.

PMID:
29650531
4.

Preeclampsia induced by STOX1 overexpression in mice induces intrauterine growth restriction, abnormal ultrasonography and BOLD MRI signatures.

Collinot H, Marchiol C, Lagoutte I, Lager F, Siauve N, Autret G, Balvay D, Renault G, Salomon LJ, Vaiman D.

J Hypertens. 2018 Jun;36(6):1399-1406. doi: 10.1097/HJH.0000000000001695.

PMID:
29465714
5.

Cationic microbubbles and antibiotic-free miniplasmid for sustained ultrasound-mediated transgene expression in liver.

Manta S, Renault G, Delalande A, Couture O, Lagoutte I, Seguin J, Lager F, Houzé P, Midoux P, Bessodes M, Scherman D, Bureau MF, Marie C, Pichon C, Mignet N.

J Control Release. 2017 Sep 28;262:170-181. doi: 10.1016/j.jconrel.2017.07.015. Epub 2017 Jul 11.

PMID:
28710005
6.

Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteers.

Depasse F, González de Suso MJ, Lagoutte I, Fontcuberta J, Borrell M, Samama MM.

Thromb Res. 2003 Jan 25;109(2-3):109-17.

PMID:
12706639

Supplemental Content

Loading ...
Support Center